Navigation Links
BioRestorative Therapies Provides Company Updates with Shareholder Letter
Date:8/1/2013

itro studies, when applied to skin cells, appears to cause a significant increase in collagen and fibronectin production (proteins that are essential for combating the aging of skin).  The Company plans to conduct additional in vitro studies to better understand the extract's mechanism of action and human cellular activity and is actively seeking collaborations with other parties to commercialize the product.
  • In mid June, financial personality and founder of NBT Equities Research, Tobin Smith, interviewed CEO Mark Weinreb with regard to the Company's hybrid business model and what it is currently doing that will help change the biotechnology landscape. Click here for the full interview: http://direct.nbtequitiesresearch.com/video/nbt-biorestorative-1
  • In late June, the Company expanded its ThermoStem® Program by collecting 150 samples of human brown adipose tissue.  This strengthens its R & D platform for the development of treatments for metabolic disorders and obesity. For the past year, through strategic collaboration and internal efforts, the Company has grown a large library of human brown fat stem cells.  The compilation of a large number and variety of brown fat derived stem cells allows it to study and identify potential cell lines to be used in developing therapies.
  • In mid July, the Company was featured in the industry publication, "The Life Sciences Report." In the interview included in the report, CEO Mark Weinreb described how the Company's cell therapy process could possibly keep disc disease treatment out of the operating theater. Link to full interview: http://www.thelifesciencesreport.com/pub/na/15470
  • Since 2011, the Company has raised approximately $9
    '/>"/>

  • SOURCE BioRestorative Therapies, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related biology technology :

    1. BioRestorative Therapies Signs Material Manufacturing Agreement With University of Utah
    2. BioRestorative Therapies to Present at 7th International Conference on Cell Therapy for Cardiovascular Disease
    3. BioRestorative Therapies Retains KCSA Strategic Communications as Investor Relations Counsel
    4. BioRestorative Therapies Obtains $2.1 Million in 2012 Private Financing
    5. BioRestorative Therapies Announces Closing of License Agreement for Adult Stem Cell Disc/Spine Procedure
    6. BioRestorative Therapies Announces Next Generation of Stem Cell Disc Delivery Device
    7. BioRestorative Therapies Enters Into Brown Fat Research Agreement With University of Utah
    8. BioRestorative Therapies Announces Stock Trading On OTC Bulletin Board
    9. BioRestorative Therapies Announces Launch of New Website
    10. BioRestorative Therapies Announces Chairman of Its Scientific Advisory Board to Speak at Vatican
    11. BioRestorative Therapies Announces the Development of an Extract that has Promise for Use in Beauty Care Products
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/29/2015)... BERGEN, Norway , May 29, 2015 ... oncology biopharmaceutical company, today announces that an abstract on ... small molecule inhibitor of the Axl receptor tyrosine kinase, ... development at BerGenBio, has been published in conjunction with ... Meeting in Chicago , May 29 ...
    (Date:5/29/2015)... 29, 2015 Delcath Systems, Inc. (NASDAQ: ... device company focused on oncology with an emphasis ... cancers, announces that results of a large, European ... patients with hepatic metastases with the Delcath Hepatic ... an on-line abstract at the American Society of ...
    (Date:5/29/2015)... Md. and RESEARCH TRIANGLE PARK, N.C. ... (NASDAQ: UTHR ) announced today that Roger Jeffs ... will provide an overview and update on the company,s business ... New York City . The presentation and ... June 4, 2015, at 11:00 AM Eastern Time, and can ...
    (Date:5/28/2015)... 2015 Research and ... addition of Jain PharmaBiotech,s new report ... Companies" to their offering. ... report deals with therapeutic drug monitoring, a ... care by monitoring drug levels in the ...
    Breaking Biology Technology:BGB324 and BGB10C9 Show Promise in Models of Pancreatic Cancer 2BGB324 and BGB10C9 Show Promise in Models of Pancreatic Cancer 3Positive Data With Delcath's CHEMOSAT Highlighted At ASCO 2015 2Positive Data With Delcath's CHEMOSAT Highlighted At ASCO 2015 3Positive Data With Delcath's CHEMOSAT Highlighted At ASCO 2015 4Positive Data With Delcath's CHEMOSAT Highlighted At ASCO 2015 5Global Therapeutic Drug Monitoring Market 2015-2024 2
    ... ... will take place on May 16-19, 2010 in Baltimore, MD, USA. This innovative ... their knowledge and experience in process development, crystallization, safety, scale-up, production, and emerging technologies. ... Columbia, MD ...
    ... Scientists at Queen,s University Belfast are developing new sensors to ... the fight against the threat of terrorist attacks. The ... or crime scene to gather a sample which is then ... of chemicals within seconds. This will allow better, faster decisions ...
    ... Batteries can power anything from small sensors to ... them smaller but even more powerful, problems can arise ... the devices themselves. University of Missouri researchers are developing ... more efficient. "To provide enough power, we need ...
    Cached Biology Technology:17th International Process Development Conference to Feature Presentations on Safety, Process Development, Crystallization, PAT, Scale-Up and Production 2New technology detects chemical weapons in seconds 2Researchers create smaller and more efficient nuclear battery 2
    (Date:5/19/2015)... 18, 2015 Fingerprint Cards (FPC) has ... FPC1145, FPC1155 and FPC1035 from one if its module partners. ... including Q3 2015 and the sensors will be used by ... values for 2015 hereby amount to 740 MSEK to date. ... 140 MSEK and a number of smaller orders not separately ...
    (Date:5/18/2015)... Fingerprint Cards (FPC) has received an ... and FPC1035 from one if its module partners. Deliveries are ... 2015 and the sensors will be used by smartphone manufacturers ... 2015 hereby amount to 740 MSEK to date. In addition ... and a number of smaller orders not separately communicated amounting ...
    (Date:5/11/2015)... May 11, 2015  Synaptics Incorporated (NASDAQ: ... solutions, today announced the appointment of Wajid ... Financial Officer, reporting to Rick Bergman , ... Chief Financial Officer, Kathleen Bayless , who ... Mr. Ali brings extensive financial management expertise ...
    Breaking Biology News(10 mins):Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 230 Million and Raises Revenue Guidance for 2015 2Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 230 Million and Raises Revenue Guidance for 2015 2Synaptics Appoints Wajid Ali as Senior Vice President and Chief Financial Officer 2
    ... Ill. Using a high-resolution single-molecule study technique, ... subtle differences between two branches of an important ... Grosman and research scientist Gisela Cymes published their ... Nicotinic-type receptors are proteins embedded in the membranes ...
    ... As the World Health Organisation suggests the E. coli ... in an outbreak O104:H4 laboratory science conducted at ... preventing the spread of such infections. Professor Bill Keevil, ... Healthcare Unit at the University of Southampton, explains: "A study ...
    ... online publication of Cell , a Cell Press publication, ... the neurodegenerative effects of both Huntington,s and Alzheimer,s disease. The ... in the breakdown of the amino acid tryptophan. ... cross the blood-brain barrier and therefore cannot act directly on ...
    Cached Biology News:Small change makes a big difference for ion channels 2Small change makes a big difference for ion channels 3Novel 'prodrug' alleviates symptoms in Huntington's and Alzheimer's mice 2
    ... protein western blot (WtPAN) is ... specific protein expression in plant ... is included in each blot ... comparison between different western blots. ...
    ...
    Immunogen: Synthetic peptide (aa sequence is considered to be commercially sensitive) Storage: -20 C, Avoid Freeze/Thaw Cycles...
    The S. cerevisiae Hansen strains are the parental yeast strains from which the deletions were derived....
    Biology Products: